Investors

EXPMARDS
All numbers in thousands USD
Period Ending
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Total Revenue
3,091
1,535
1,000
1,022
Cost of Revenue
33,084
--
--
--
Gross Profit
3,091
1,535
--
--
Operating Expenses
Research Development
25,923
36,936
16,956
24,083
Selling General and Administrative
7,161
7,310
6,445
6,026
Non Recurring
--
--
--
--
Others
(3,091)
0
0
0
Total Operating Expenses
29,993
44,246
23,401
30,109
Operating Income or Loss
(29,993)
(42,711)
(22,401)
(29,087)
Income from Continuing Operations
Total Other Income/Expenses Net
(257)
(796)
(9)
(951)
Earnings Before Interest And Taxes
(29,993)
(41,915)
(22,401)
(29,087)
Interest Expense
--
--
--
--
Income Before Tax
(30,371)
(42,160)
(22,333)
(29,681)
Income Tax Expense
435
(28)
--
--
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(30,371)
(42,193)
(22,333)
(29,681)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(30,371)
(42,193)
(22,333)
(29,681)
Preferred Stock And Other Adjustments
--
4,127
--
--
Net Income Applicable To Common Shares
(30,371)
(46,320)
(22,333)
(29,681)